Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.04

+2.6%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (385)	6/22/1998 2:34:00 PM
From: B.REVERE	Read Replies (1) of 1722

[ZELDOX DELAY]----Anthony, PFE rep says relatively short time frame to address concerns. A little vague but sounded like they can address the concerns within reasonable limits. Since only about 50 mill rev. was expected this year, the stock appears to have digested the news with not much of a pullback. "company spokesman, Andy McCormick would not comment on the letter's specifics, saying only the FDA "raises issues we intend to respond to." McCormick said Pfizer intends on meeting with the FDA to talk about the issues the agency raised and to respond to the FDA's suggestion to submit additional data on the drug for review. "We believe that the additional studies and analyses suggested by the FDA can be undertaken in a relatively short period, and that we will be able to advance the application accordingly," research and development executive vice president John Niblack said.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next